Alphatec ATEC Stock Why Cost Reduction Slight Downtick 20260415 EYPT EyePoint stock gains despite missing earnings and posting 275 revenue decline investors see turnaround signs IPHA Innate Pharma SA ADS climbs 368 percent despite sharp Q1 2026 EPS and revenue misses versus analyst estimates How Pangaea PANL manages counterparty exposure PANL Q4 Earnings Pangaea Misses Estimates as Costs Rise AIZ Q1 2026 Earnings EPS Surges 113 Above Estimates Stock Edges Lower BXP Q1 2026 Earnings Earnings Beat Estimates by Wide Margin Stock Edges Higher CGNX Q1 2026 Earnings Robust EPS Surprise Overshadowed by Revenue Disappointment SCM Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds GLUE Q1 2026 Earnings WiderThanExpected Loss as PreClinical Biotech Advances Pipeline